Suppr超能文献

疾病管理项目:成本基准、节省金额、投资回报率

Disease management programs: benchmarking costs, savings, ROI.

出版信息

Healthc Benchmarks. 1998 Aug;5(8):117-9.

Abstract

Consumer and employer demands, financial pressures, and accreditation requirements have propelled disease management into its own fledgling industry, but there is still no one-stop shop for information, at least not for free. Experts suggest using a disease management vendor's guaranteed savings, not the fee per patient, as a benchmark. Middle- to high-priced vendors are generally the most cost-effective. Factors that affect costs include your patient mix, the amount of risk you want the vendor to assume, and how many bells and whistles you want in your program.

摘要

消费者和雇主的需求、财务压力以及认证要求已将疾病管理推进到其刚起步的行业,但仍没有一站式的信息服务,至少没有免费的。专家建议以疾病管理供应商保证的节省费用,而非每位患者的费用,作为基准。中高价供应商通常最具成本效益。影响成本的因素包括你的患者组合、你希望供应商承担的风险量,以及你的项目想要多少额外功能。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验